1-20 of 144
Sort by
News

Phase III BASIS Trial Shows Positive Results for Marstacimab in Patients with Hemophilia A, B With Inhibitors

Free
Ruth Jessen Hickman, MD
Published: 2025
Abstract
January 2026
View News titled, Phase III BASIS Trial Shows Positive Results for Marstacimab in Patients with Hemophilia A, B With Inhibitors
News

Study Identifies Potential Surrogate Marker for Bleeding Risk in AHA with Emicizumab

Free
Ruth Jessen Hickman, MD
Published: 2025
Abstract
December 2025
View News titled, Study Identifies Potential Surrogate Marker for Bleeding Risk in AHA with Emicizumab
News

Marstacimab Provides New Prophylactic Option for Hemophilia A, B

Free
Ruth Jessen Hickman, MD
Published: 2025
Abstract
September 2025
View News titled, Marstacimab Provides New Prophylactic Option for Hemophilia A, B
News

Phase IIIb Results Show Avatrombopag to Be Safe, Effective Treatment for Children With ITP

Free
Lara C. Pullen, PhD
Published: 2025
Abstract
September 2025
View News titled, Phase IIIb Results Show Avatrombopag to Be Safe, Effective Treatment for Children With ITP
News

Nurse-Led Multidisciplinary Pathway Developed to Optimize Patient Journey in Acquired Hemophilia A

Free
Katie Robinson
Published: 2025
Abstract
August 2025
View News titled, Nurse-Led Multidisciplinary Pathway Developed to Optimize Patient Journey in Acquired Hemophilia A
News

Exploring Heterozygote Bleeding Risk in Rare Bleeding Disorders

Free
Ruth Jessen Hickman, MD
Published: 2025
Abstract
August 2025
View News titled, Exploring Heterozygote Bleeding Risk in Rare Bleeding Disorders
News

Marstacimab Shows Long-Term Efficacy in Severe Hemophilia A, B Without Inhibitors

Free
Katie Robinson
Published: 2025
Abstract
August 2025
View News titled, Marstacimab Shows Long-Term Efficacy in Severe Hemophilia A, B Without Inhibitors
News

Concizumab Reduced Annualized Bleeding Rates in Hemophilia A, B Regardless of Target Joints

Free
Katie Robinson
Published: 2025
Abstract
August 2025
View News titled, Concizumab Reduced Annualized Bleeding Rates in Hemophilia A, B Regardless of Target Joints
News

Daratumumab Shows Efficacy, Safety in Phase II Study of Previously Treated ITP

Free
Katie Robinson
Published: 2025
Abstract
August 2025
View News titled, Daratumumab Shows Efficacy, Safety in Phase II Study of Previously Treated ITP
News

Iron Deficiency Potentially Underdiagnosed in Females With Bleeding Disorders

Free
Ruth Jessen Hickman, MD
Published: 2025
Abstract
July 2025
View News titled, Iron Deficiency Potentially Underdiagnosed in Females With Bleeding Disorders
News

Rilzabrutinib Offers Significant Advantages for Treatment of ITP

Free
Published: 2025
Abstract
July 2025
View News titled, Rilzabrutinib Offers Significant Advantages for Treatment of ITP
News

Another Potential Product for Fibrinogen Concentrate for Congenital Fibrinogen Deficiency

Free
Ruth Jessen Hickman, MD
Published: 2025
Abstract
July 2025
View News titled, Another Potential Product for Fibrinogen Concentrate for Congenital Fibrinogen Deficiency
News

Oral Thrombopoietin Receptor Agonist Eltrombopag Also Functions as Iron Chelator, Study Finds

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
June 2025
View News titled, Oral Thrombopoietin Receptor Agonist Eltrombopag Also Functions as Iron Chelator, Study Finds
News

ITP in Children Could Be Added Indication for Avatrombopag

Free
Published: 2025
Abstract
June 2025
View News titled, ITP in Children Could Be Added Indication for Avatrombopag
News

Intensive Factor VIII Prophylaxis May Benefit Patients with Hemophilia, Hypertrophic Synovium

Free
Ruth Jessen Hickman, MD
Published: 2025
Abstract
May 2025
View News titled, Intensive Factor VIII Prophylaxis May Benefit Patients with Hemophilia, Hypertrophic Synovium
News

Short-Term Benefit Seen With Tranexamic Acid in Hemarthrosis, but Questions Persist

Free
Thomas R. Collins
Published: 2025
Abstract
April 2025
View News titled, Short-Term Benefit Seen With Tranexamic Acid in Hemarthrosis, but Questions Persist
News

miRNA Identified as Potential ITP Diagnostic Biomarker

Free
Leah Lawrence
Published: 2025
Abstract
April 2025
View News titled, miRNA Identified as Potential ITP Diagnostic Biomarker
News

Fitusiran on the Horizon for Hemophilia

Free
Published: 2025
Abstract
March 2025
View News titled, Fitusiran on the Horizon for Hemophilia
News

AI-Assisted POCUS Could Help Identify Joint Bleeds in Hemophilia

Free
Leah Lawrence
Published: 2025
Abstract
March 2025
View News titled, AI-Assisted POCUS Could Help Identify Joint Bleeds in Hemophilia
News

Bevacizumab in Hereditary Hemorrhagic Telangiectasia (TRUST-HHT; NCT04404881)

Free
Lara C. Pullen, PhD
Published: 2025
Abstract
February 2025
View News titled, Bevacizumab in Hereditary Hemorrhagic Telangiectasia (TRUST-HHT; NCT04404881)